Vaccine inequity and hesitancy: Dual factors in the emergence of novel SARS-CoV-2 variants.
作者信息
Dhawan Manish, Sahni Ashima, Choudhary Om Prakash
机构信息
Department of Microbiology, Punjab Agricultural University, Ludhiana, 141004, Punjab, India.
The Trafford Group of Colleges, Manchester, WA14 5PQ, UK.
出版信息
Ann Med Surg (Lond). 2022 Jan;73:103186. doi: 10.1016/j.amsu.2021.103186. Epub 2021 Dec 23.
Abstract
摘要
相似文献
1
Vaccine inequity and hesitancy: Dual factors in the emergence of novel SARS-CoV-2 variants.疫苗不平等与犹豫：新型SARS-CoV-2变体出现的双重因素
Ann Med Surg (Lond). 2022 Jan;73:103186. doi: 10.1016/j.amsu.2021.103186. Epub 2021 Dec 23.
2
SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.SARS-CoV-2 变体和疫苗接种率在 Delta 变体出现期间面临的全球大流行：一项旨在寻找疫苗犹豫原因的全国性调查。
J Infect Public Health. 2022 Jul;15(7):773-780. doi: 10.1016/j.jiph.2022.06.007. Epub 2022 Jun 17.
3
Near-Complete SARS-CoV-2 Seroprevalence among Rural and Urban Kenyans despite Significant Vaccine Hesitancy and Refusal.尽管存在严重的疫苗犹豫和拒绝现象，但肯尼亚城乡居民中SARS-CoV-2血清阳性率接近完全覆盖。
Vaccines (Basel). 2022 Dec 28;11(1):68. doi: 10.3390/vaccines11010068.
4
SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy.SARS-CoV-2 即亚洲病毒（佐剂诱导的自身免疫/炎症综合征），存在不孕和疫苗犹豫的风险。
Expert Rev Vaccines. 2022 Sep;21(9):1177-1184. doi: 10.1080/14760584.2022.2089120. Epub 2022 Jul 1.
5
Adjudicating the logistics of COVID-19 vaccine boosters from a global perspective.从全球视角裁定 COVID-19 疫苗加强针的物流问题。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2020572. doi: 10.1080/21645515.2021.2020572. Epub 2022 Jan 13.
6
Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey.香港地区 SARS-CoV-2 疫苗犹豫的流行情况及其决定因素：一项基于人群的调查。
Vaccine. 2021 Jun 16;39(27):3602-3607. doi: 10.1016/j.vaccine.2021.05.036. Epub 2021 May 18.
7
COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake.COVID-19 疫苗犹豫：对犹豫的考虑因素和提高疫苗接种率。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2062972. doi: 10.1080/21645515.2022.2062972. Epub 2022 Apr 18.
8
9
Explore the reasons for SARS-CoV-2 vaccine hesitancy among healthcare workers: a cross-sectional study.探索医护人员对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗犹豫的原因：一项横断面研究。
Ann Med Surg (Lond). 2023 Apr 14;85(6):2443-2450. doi: 10.1097/MS9.0000000000000628. eCollection 2023 Jun.
10
[The determinants of SARS-CoV-2 vaccine hesitancy in a rural area of an Indonesia-Philippines border island: A mixed-method study].[印度尼西亚-菲律宾边境岛屿农村地区对2019冠状病毒病疫苗犹豫的决定因素：一项混合方法研究]
Enferm Clin. 2022 Nov-Dec;32(6):376-384. doi: 10.1016/j.enfcli.2022.02.001. Epub 2022 Mar 3.
引用本文的文献
1
"The COVID-19 pandemic in BRICS: Milestones, interventions, and molecular epidemiology".金砖国家的新冠疫情：里程碑、应对措施及分子流行病学
PLOS Glob Public Health. 2024 Dec 20;4(12):e0003023. doi: 10.1371/journal.pgph.0003023. eCollection 2024.
2
Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine.接种三种类型的 SARS-CoV-2 疫苗后的体液免疫原性评估。
Sci Rep. 2023 Nov 18;13(1):20213. doi: 10.1038/s41598-023-47611-w.
3
Community dialogue meetings among district leaders improved their willingness to receive COVID-19 vaccines in Western Uganda, May 2021.在乌干达西部，地区领导之间的社区对话会议提高了他们对接种 COVID-19 疫苗的意愿，2021 年 5 月。
BMC Public Health. 2023 May 26;23(1):969. doi: 10.1186/s12889-023-15903-5.
4
Omicron with threatened antagonistic consequences and are convoyed by new fangled risks - Correspondence.奥密克戎具有潜在的对抗性后果，并伴随着新出现的风险——通信。
Int J Surg. 2022 Oct;106:106947. doi: 10.1016/j.ijsu.2022.106947. Epub 2022 Sep 22.
5
Clinical Performance of Three Commercial SARS-CoV-2 Rapid Antigen Tests for Community-Dwelling Individuals in a Tropical Setting.三种商业 SARS-CoV-2 快速抗原检测试剂在热带环境下社区居住人群中的临床性能评估。
Front Cell Infect Microbiol. 2022 Jul 5;12:832235. doi: 10.3389/fcimb.2022.832235. eCollection 2022.
6
Vaccine apartheid: the separation of the world's poorest and most vulnerable and the birth of Omicron.疫苗种族隔离：世界上最贫穷、最脆弱人群的分化与奥密克戎的诞生
Ther Adv Vaccines Immunother. 2022 Jul 5;10:25151355221107975. doi: 10.1177/25151355221107975. eCollection 2022.
7
COVID-19 Vaccine Uptake in the Context of the First Delta Outbreak in China During the Early Summer of 2021: The Role of Geographical Distance and Vaccine Talk.2021年初夏中国首次德尔塔毒株疫情期间的新冠疫苗接种情况：地理距离和疫苗讨论的作用
Risk Manag Healthc Policy. 2022 Jun 10;15:1203-1214. doi: 10.2147/RMHP.S361024. eCollection 2022.
8
Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions.了解严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的奥密克戎变种（B.1.1.529）：突变影响、问题及可能的解决方案。
Ann Med Surg (Lond). 2022 Jun;78:103737. doi: 10.1016/j.amsu.2022.103737. Epub 2022 May 7.
9
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.德尔塔变异株（B.1.617.2）：SARS-CoV-2 的突变、影响、挑战及可能的解决方案。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2068883. doi: 10.1080/21645515.2022.2068883. Epub 2022 May 4.
10
Immunomodulatory effects of zinc and its impact on COVID-19 severity.锌的免疫调节作用及其对新冠病毒疾病严重程度的影响。
Ann Med Surg (Lond). 2022 May;77:103638. doi: 10.1016/j.amsu.2022.103638. Epub 2022 Apr 16.
本文引用的文献
1
Omicron variant (B.1.1.529) of SARS-CoV-2: Threat assessment and plan of action.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的奥密克戎变异株（B.1.1.529）：威胁评估与行动计划
Int J Surg. 2022 Jan;97:106187. doi: 10.1016/j.ijsu.2021.106187. Epub 2021 Dec 9.
2
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变异毒株奥密克戎（B.1.1.529）的出现——凸显了非洲的研究能力，但也暴露了重大的知识空白、疫苗分配不公、全球新冠疫情应对和防控工作的不足。
Int J Infect Dis. 2022 Jan;114:268-272. doi: 10.1016/j.ijid.2021.11.040. Epub 2021 Dec 1.
3
Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert!严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的奥密克戎变异株（B.1.1.529），全球紧急公共卫生警报！
J Med Virol. 2022 Apr;94(4):1255-1256. doi: 10.1002/jmv.27491. Epub 2021 Dec 7.
4
COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.新冠病毒疫苗犹豫 - 实现成功的全球疫苗接种运动以应对当前大流行的原因和解决方案。
Hum Vaccin Immunother. 2021 Oct 3;17(10):3495-3499. doi: 10.1080/21645515.2021.1926183. Epub 2021 Jun 30.
5
Making sound public health policy decisions for COVID-19 vaccination: vaccine effectiveness, safety, affordability, programmatic logistics and roll-out globally.为新冠疫苗接种制定合理的公共卫生政策决策：疫苗有效性、安全性、可负担性、规划物流及全球推广。
J Travel Med. 2021 Mar 5. doi: 10.1093/jtm/taab031.
Zotero 插件